CRIS - Curis, Inc. Company Long-Term Liabilities

Public company logo of curis.com (CRIS)

This chart of debt obligation price action for Curis, Inc. (CRIS) reflects the dynamics of a company developing anti-tumor agents through strategic partnerships with biotech giants, with the indicator standing at 0.00. The brand is valued within the scientific community for developing low-toxicity compounds that target the signaling mechanisms of neoplasms. The business is currently focusing on independent development and seeking capital to complete clinical trials for its leukemia drug.

Curis, Inc. (CRIS) Company Long-Term Debt: for the period 07/04/2022 - 10/30/2026

Curis (CRIS) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price Curis Inc.|CRIS - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation Curis|CRIS - Enterprise Value
- shareholders' equity book value data:
Net Asset Value per Share Curis|CRIS - Company Book Value|Market Value to Book Value curis.com|CRIS - Cumulative Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Curis, Inc.|CRIS - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Curis Inc.|CRIS - Company Total Debt|Debts to Book Capitalization Curis|CRIS - Company Long-Term Debt|Company Short-Term Loans and Borrowings Curis|Immediate Liquidity curis.com
- earnings and market multiples details:
CRIS - Net Profit
Fundamental company valuation:CRIS (Curis, Inc.)
Brand item of Curis Corp

For the biotech company Curis, Inc. (CRIS), which focuses on the clinical validation of targeted lymphoma drugs, debt capital serves as a tool to ensure operational stability until product commercialization. By analyzing the issuer's long-term liabilities chart, an investor assesses the aggregate of loans with maturities exceeding one year, which allows for the determination of financial leverage and liquidity risks during long-term capital expenditure planning.

Competitors of Curis, Inc. (CRIS)

ONC: Company Long-Term Indebtedness|Halozyme - Company Long-Term Debts|Revolution Medicines Inc (RVMD) - Company Long-Term Liabilities|AAPG: Company Long-Term Debts|Long-Term Debt CG Oncology Therapeutics (CGON)|Company Long-Term Debt UroGen Pharma Ltd.|BCAX: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities PSNL (Personalis)|ERAS (Erasca Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts DCTH (Delcath)|YMAB - Company Long-Term Liabilities|AURA: Company Long-Term Liabilities|CADL - Company Long-Term Debts|Accuray (ARAY) - Company Long-Term Debt|SELLAS Life Sciences Group - Company Long-Term Loans and Borrowings|ACTU (Actuate Therapeutics, Inc) - Company Long-Term Debts|Long-Term Debt Citius Oncology Inc CTOR|Company Long-Term Debts HURA|Company Long-Term Liabilities protaratx.com TARA|Fate Therapeutics - Company Long-Term Liabilities|Company Long-Term Debts Aadi Bioscience, Inc. WHWK|TCRX - Company Long-Term Debt|Company Long-Term Loans and Borrowings CSBR (Champions Oncology)|XBIT: Company Long-Term Debts|CVM - Long-Term Debt Volume|Company Long-Term Debt OS Therapies|Radiopharm Theranostics Ltd (RADX) - Long-Term Debt Volume|Company Long-Term Liabilities ARTV (Artiva Biotherapeutics, Inc.)|ANL (adlainortye.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts VERU (Veru Inc.)|Long-Term Debt Volume tempesttx.com (TPST)|XLO - Company Long-Term Debt|RENB (Renovaro Inc.) - Company Long-Term Indebtedness|MURA: Company Long-Term Debts|Company Long-Term Liabilities Kairos Pharma|Company Long-Term Liabilities OKUR|CytoMed (GDTC) - Long-Term Debt Volume|Company Long-Term Debts APLM|Company Long-Term Liabilities Tharimmune Inc THAR|Company Long-Term Debt Advanced Biomed ADVB|Company Long-Term Loans and Borrowings GNPX|Calidi Bio - Company Long-Term Debts|Long-Term Debt Volume Sunshine Biopharma Inc. SBFM|xeneticbio.com (XBIO) - Company Long-Term Debt|SLRX - Long-Term Debt Volume|PPBT (Purple Biotech Corp) - Company Long-Term Debts|Company Long-Term Liabilities AON (AONC)|Company Long-Term Debts BGNE|Company Long-Term Debts checkpointtx.com (CKPT)|Company Long-Term Debt Elevation Oncology, Inc. ELEV|ICAD: Company Long-Term Indebtedness|Ikena - Company Long-Term Debts|Notable Labs Corp (NTBL) - Company Long-Term Liabilities|VIRX: Company Long-Term Debts|Long-Term Debt morphosys.com (MOR)|Company Long-Term Debt NAYA Biosciences Inc.|AAPGV: Company Long-Term Loans and Borrowings